西川和男 (Kazuo Nishikawa) - マイポータル

基本情報

所属: 大分大学医学部附属病院腫瘍内科助教

研究者番号: 70636399
J-GLOBAL ID: 202401013418593601
researchmap会員ID: R000077466

論文

Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study.

Takafumi Hashimoto, Takashi Karashima, Kosuke Kamada, Kaori Ogata, Kazuki Ohta, Yuta Abe, Takahiro Sato, Daiki Noda, Miyuki Abe, Naoki Haratake …

Journal of thoracic disease 18(2) 89-89 2026年2月28日査読有り
Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous Biomarker.

Takahiro Sumimoto, Ryota Tanaka, Yosuke Suzuki, Jun Negami, Yoshio Sueshige, Ayako Oda, Ken Shiraiwa, Takashi Inagaki, Kazuo Nishikawa, Ryosuke Tatsuta …

Clinical pharmacology and therapeutics 118(1) 128-137 2025年7月査読有り
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).

Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, Taiga Otsuka, Kohei Hayashi, Takuya Honda, Kazuhiko Nakao, Taro Shibuki, Junichi Nakazawa, Shiho Arima …

Scientific reports 15(1) 3427-3427 2025年1月27日査読有り
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.

Tomonori Araki, Machiko Kawahira, Mototsugu Shimokawa, Taiga Otsuka, Kohei Hayashi, Yuki Sonoda, Takuya Honda, Kazuhiko Nakao, Taro Shibuki, Junichi Nakazawa …

Oncology 103(7) 569-579 2025年査読有り
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302).

Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, Taiga Otsuka, Yuki Sonoda, Takuya Honda, Taro Shibuki, Junichi Nakazawa, Shiho Arima, Keisuke Miwa …

Therapeutic advances in medical oncology 17 17588359251320768-17588359251320768 2025年査読有り
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.

Taro Shibuki, Taiga Otsuka, Mototsugu Shimokawa, Junichi Nakazawa, Shiho Arima, Masaru Fukahori, Keisuke Miwa, Yoshinobu Okabe, Futa Koga, Yujiro Ueda …

Scientific reports 14(1) 16906-16906 2024年7月23日査読有り
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.

Tomoko Kodama, Takashi Imajima, Mototsugu Shimokawa, Taiga Otsuka, Masahiro Kawahira, Junichi Nakazawa, Takeshi Hori, Taro Shibuki, Shiho Arima, Akio Ido …

Scientific reports 14(1) 12422-12422 2024年5月30日査読有り
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.

Takashi Kasai, Kiyoshi Mori, Yoichi Nakamura, Nobuhiko Seki, Yasuko Ichikawa, Haruhiro Saito, Tetsuro Kondo, Kazuo Nishikawa, Satoshi Otsu, Akihiro Bessho …

Cancer medicine 12(14) 14988-14999 2023年7月査読有り
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.

Kazuo Nishikawa, Shuichi Hironaka, Takashi Inagaki, Azusa Komori, Satoshi Otsu, Kenji Mitsugi, Akitaka Makiyama, Koichiro Watanabe, Shingo Tamura, Yuta Okumura …

Japanese journal of clinical oncology 52(12) 1416-1422 2022年12月5日査読有り
当院における非小細胞肺癌に対する癌免疫療法の免疫関連有害事象と治療成績の関係

橋本崇史, 辛島高志, 安部美幸, 内匠陽平, 宮脇美千代, 小副川敦, 稲墻崇, 西川和男, 大津智, 杉尾賢二

日本癌治療学会学術集会抄録集 60回 O71-2 2022年10月
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yutaka Kimura, Kenji Amagai …

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24(2) 467-476 2021年3月査読有り
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yutaka Kimura, Kenji Amagai …

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24(2) 477-478 2021年3月
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Yuko Tsuchiya-Kawano, Tomonari Sasaki, Hiroyuki Yamaguchi, Katsuya Hirano, Atsushi Horiike, Miyako Satouchi, Shinobu Hosokawa, Ryotaro Morinaga, Kazutoshi Komiya, Koji Inoue …

The oncologist 25(6) 475-e891 2020年6月査読有り
Gastric Carcinoma as Second Malignant Neoplasm in a Survivor From High-risk Neuroblastoma.

Naoki Hirano, Kazuo Nishikawa, Takahiro Hiratsuka, Souichi Suenobu, Kenji Ihara

Journal of pediatric hematology/oncology 42(2) 160-162 2020年3月査読有り
Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.

Yuko Kawano, Tomonari Sasaki, Hiroyuki Yamaguchi, Katsuya Hirano, Atsushi Horiike, Miyako Satouchi, Shinobu Hosokawa, Ryotaro Morinaga, Kazutoshi Komiya, Koji Inoue …

Lung cancer (Amsterdam, Netherlands) 125 136-141 2018年11月査読有り
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).

Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka, Misuzu Mori, Kazuhiro Nishikawa, Shinya Tokunaga, Hiroyuki Okuda, Takeshi Sakamoto, Keisei Taku, Kazuo Nishikawa …

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 21(1) 84-95 2018年1月査読有り
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.

Kazuhiko Yamada, Masao Ichiki, Kazuhisa Takahashi, Yasushi Hisamatsu, Hiroaki Takeoka, Koichi Azuma, Takehito Shukuya, Kazuo Nishikawa, Takaaki Tokito, Hidenobu Ishii …

Cancer chemotherapy and pharmacology 78(3) 501-7 2016年9月査読有り
Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab.

Satoshi Otsu, Yoshinori Hirashima, Kazuo Nishikawa, Hiroyuki Sakashita, Ryotaro Morinaga, Koichiro Watanabe, Kuniaki Shirao

Japanese clinical medicine 5 19-23 2014年査読有り
Ectopic hepatocellular carcinoma of the left sub-diaphragm with metastasis.

Kazuo Nishikawa, Koichiro Watanabe, Yasushi Hisamatsu, Kuniaki Shirao

Internal medicine (Tokyo, Japan) 50(14) 1505-6 2011年査読有り

MISC

切除不能III期非小細胞肺がんにおける根治的化学放射線療法後durvalumabの前向きbiomarker試験(WJOG11518L)

豆鞘伸昭, 原谷浩司, 山口哲平, 関根朗雅, 三浦理, 岩永健太郎, 山口正史, 西川和男, 水柿秀紀, 工藤慶太 …

日本臨床腫瘍学会学術集会(CD-ROM) 21st 2024年
高齢者切除不能膵癌に対するNAL-IRI/FU/LV療法の効果と安全性の最終解析

瀧川彩, 在田修二, 下川元継, 大塚大河, 中澤潤一, 下川穂積, 古賀風太, 小田尚伸, 竹下茂之, 河口康典 …

日本癌治療学会学術集会(Web) 62nd 2024年
脈絡膜転移に対して緩和照射を施行した3例

清田貴茂, 高田彰子, 松本陽, 大塚誠, 糸谷真保, 足立徹, 大木玲子, 木許賢一, 小副川敦, 杉尾賢二 …

Palliative Care Research (Web) 17(1) 2022年
非小細胞肺癌外科手術後再発症例に対する癌免疫療法の治療成績に関する解析

橋本崇史, 辛島高志, 安部美幸, 内匠陽平, 宮脇美千代, 小副川敦, 稲墻崇, 西川和男, 杉尾賢二

日本肺癌学会学術集会号(CD-ROM) 63rd 2022年
免疫チェックポイント阻害薬投与患者の血清学的効果予測因子の検討

辛島高志, 安部美幸, 稲墻崇, 西川和男, 内匠陽平, 橋本崇史, 宮脇美千代, 小副川敦, 杉尾賢二

日本肺癌学会学術集会号(CD-ROM) 63rd 2022年

共同研究・競争的資金等の研究課題

制御性Ｔ細胞がＥＧＦＲ阻害剤の耐性獲得機序に関連しているか

日本学術振興会科学研究費助成事業基盤研究(C) 2011年4月 - 2015年3月

渡邉浩一郎, 白尾国昭, 波多野豊, 大津智, 森永亮太郎, 平島詳典, 久松靖史, 西川和男, 河野桜